Annual Cash & Cash Equivalents
$39.59 M
+$15.46 M+64.07%
December 31, 2023
Summary
- As of February 8, 2025, TARA annual cash & cash equivalents is $39.59 million, with the most recent change of +$15.46 million (+64.07%) on December 31, 2023.
- During the last 3 years, TARA annual cash & cash equivalents has fallen by -$129.01 million (-76.52%).
- TARA annual cash & cash equivalents is now -76.52% below its all-time high of $168.60 million, reached on December 31, 2020.
Performance
TARA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$51.76 M
-$37.82 M-42.22%
September 30, 2024
Summary
- As of February 8, 2025, TARA quarterly cash and cash equivalents is $51.76 million, with the most recent change of -$37.82 million (-42.22%) on September 30, 2024.
- Over the past year, TARA quarterly cash and cash equivalents has increased by +$17.99 million (+53.27%).
- TARA quarterly cash and cash equivalents is now -69.30% below its all-time high of $168.60 million, reached on December 31, 2020.
Performance
TARA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TARA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +64.1% | +53.3% |
| 3 y3 years | -76.5% | +53.3% |
| 5 y5 years | +104.4% | +53.3% |
TARA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +64.1% | -42.2% | +146.1% |
| 5 y | 5-year | -76.5% | +6918.8% | -69.3% | +9076.8% |
| alltime | all time | -76.5% | +6918.8% | -69.3% | +9076.8% |
Protara Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $51.76 M(-42.2%) |
| Jun 2024 | - | $89.58 M(+71.5%) |
| Mar 2024 | - | $52.23 M(+31.9%) |
| Dec 2023 | $39.59 M(+64.1%) | $39.59 M(+17.2%) |
| Sep 2023 | - | $33.77 M(-0.6%) |
| Jun 2023 | - | $33.98 M(+61.5%) |
| Mar 2023 | - | $21.04 M(-12.8%) |
| Dec 2022 | $24.13 M(-32.5%) | $24.13 M(-49.2%) |
| Sep 2022 | - | $47.50 M(+40.5%) |
| Jun 2022 | - | $33.81 M(+32.9%) |
| Mar 2022 | - | $25.44 M(-28.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $35.72 M(-78.8%) | $35.72 M(-12.3%) |
| Sep 2021 | - | $40.74 M(-13.0%) |
| Jun 2021 | - | $46.84 M(-19.5%) |
| Mar 2021 | - | $58.20 M(-65.5%) |
| Dec 2020 | $168.60 M(>+9900.0%) | $168.60 M(+1.6%) |
| Sep 2020 | - | $165.90 M(+453.6%) |
| Jun 2020 | - | $29.97 M(-16.9%) |
| Mar 2020 | - | $36.07 M(+6295.2%) |
| Dec 2019 | $564.00 K(-97.1%) | $564.00 K(-98.7%) |
| Sep 2019 | - | $41.86 M |
| Dec 2018 | $19.37 M | - |
FAQ
- What is Protara Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Protara Therapeutics?
- What is Protara Therapeutics annual cash & cash equivalents year-on-year change?
- What is Protara Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Protara Therapeutics?
- What is Protara Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Protara Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of TARA is $39.59 M
What is the all time high annual cash & cash equivalents for Protara Therapeutics?
Protara Therapeutics all-time high annual cash & cash equivalents is $168.60 M
What is Protara Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, TARA annual cash & cash equivalents has changed by +$15.46 M (+64.07%)
What is Protara Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TARA is $51.76 M
What is the all time high quarterly cash and cash equivalents for Protara Therapeutics?
Protara Therapeutics all-time high quarterly cash and cash equivalents is $168.60 M
What is Protara Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, TARA quarterly cash and cash equivalents has changed by +$17.99 M (+53.27%)